Cargando…
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
BACKGROUND: There is little evidence about the relationship between aetiology, illness severity, and clinical course of respiratory tract infections (RTIs) in primary care. Understanding these associations would aid in the development of effective management strategies for these infections. AIM: To...
Autores principales: | Verheij, Theo J, Cianci, Daniela, van der Velden, Alike W, Butler, Christopher C, Bongard, Emily, Coenen, Samuel, Colliers, Annelies, Francis, Nick A, Little, Paul, Godycki-Cwirko, Maciek, Llor, Carl, Chlabicz, Sławomir, Lionis, Christos, Sundvall, Pär-Daniel, Bjerrum, Lars, De Sutter, An, Aabenhus, Rune, Harbin, Nicolay Jonassen, Lindbæk, Morten, Glinz, Dominik, Bucher, Heiner C, Kovács, Bernadett, Seifert, Bohumil, Jurgute, Ruta Radzeviciene, Lundgren, Pia Touboul, de Paor, Muireann, Matheeussen, Veerle, Goossens, Herman, Ieven, Margareta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803087/ https://www.ncbi.nlm.nih.gov/pubmed/34990385 http://dx.doi.org/10.3399/BJGP.2021.0344 |
Ejemplares similares
-
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC(4)E trial in 15 European countries
por: Li, Xiao, et al.
Publicado: (2022) -
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC(4) E): the ALIC(4) E protocol
por: Bongard, Emily, et al.
Publicado: (2018) -
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC(4)E Trial
por: Li, Xiao, et al.
Publicado: (2021) -
Is C-reactive protein associated with influenza A or B in primary care patients with influenza-like illness? A cross-sectional study
por: Rystedt, Karin, et al.
Publicado: (2020) -
Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis
por: Harbin, Nicolay Jonassen, et al.
Publicado: (2021)